Results 71 to 80 of about 2,024,265 (255)

Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry [PDF]

, 2023
Sukrit Treewaree, Gregory Y.H. Lip, Rungroj Krittayaphong   +2 more
openalex   +1 more source

Manejo terapéutico de los usuarios con terapia anticoagulante oral [PDF]

, 2016
Objective: Characterize the users of oral anticoagulant therapy; to find out about treatment regimen management and to estimate International Normalized Ratio (INR) assessment costs.
Gemito, Laurência, Mendes, Felismina, Ribeiro, Lurdes, Serra, Isaura   +3 more
core  

Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis? [PDF]

, 2019
Porto sinusoidal vascular liver disease (PSVD) and portal vein thrombosis (PVT) are distinct vascular liver diseases characterized, respectively, by an intrahepatic and a prehepatic obstacle to the flow in the liver portal system. PVT may also occur as a
D'Amati, G., Gioia, S., Nardelli, S., Ridola, L., Riggio, O.   +4 more
core   +1 more source

Self-Inflicted Intraoral Hematoma in a Cardiac Patient Receiving Oral Anticoagulant Therapy- A Case Report [PDF]

Journal of Krishna Institute of Medical Sciences University, 2015
Intraoral hematoma secondary to systemic anticoagulant therapy is rare, but it is a potentially fatal condition requiring immediate medical management.
Shantala Arunkumar , Preethi A. Poonja, Shyam Amur, Atul P. Sattur , Krishna N. Burde, Venkatesh S Anehosur   +5 more
doaj  

Performing diagnostic radial access coronary angiography on uninterrupted direct oral anticoagulant therapy: a prospective analysis

Open Heart, 2019
Purpose We sought to assess the safety of performing diagnostic radial access coronary angiography with uninterrupted anticoagulation on patients receiving direct oral anticoagulant therapy.Background Direct oral anticoagulants have become a popular ...
Napohn Chongprasertpon, Samer Arnous, Thomas John Kiernan, Aiste Zebrauskaite, John Joseph Coughlan, Abdalla Ibrahim, Terence Hennessy   +6 more
doaj   +1 more source

Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010–2017

Pharmacotherapy, 2018
Since 2010, several non–vitamin K antagonist oral anticoagulants (NOACs) have been brought to the U.S. market, yet little is known regarding their evolving adoption for prophylaxis of atrial fibrillation (AF)‐related stroke.
Junya Zhu, G. Alexander, S. Nazarian, Jodi B. Segal, A. Wu   +4 more
semanticscholar   +1 more source

Enhancement and evaluation of a prescription audit system for direct oral anticoagulants using a check sheet

Journal of Pharmaceutical Health Care and Sciences, 2021
Background Renal function and use of concomitant medications should be carefully monitored in patients subjected to treatment with direct oral anticoagulants (DOACs); the dose should be individually designed for each patient.
Naoto Ishikawa, Hanae Oshikiri, Shinya Takasaki, Masafumi Kikuchi, Taku Obara, Kazutoshi Akasaka, Masaki Matsuura, Hiroaki Yamaguchi, Nariyasu Mano   +8 more
doaj   +1 more source

XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation. [PDF]

, 2014
Atrial fibrillation (AF) is associated with a fivefold increase in the risk of stroke. The Phase III ROCKET AF (Rivaroxaban Once-Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in ...
Amarenco, P, Camm, AJ, Haas, S, Hess, S, Kirchhof, P, Turpie, AG, van Eickels, M   +6 more
core   +2 more sources

Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background A rapid shift has occurred from vitamin K antagonists toward direct oral anticoagulants, which have a lower risk of intracerebral hemorrhage (ICH). However, effects on clinical outcomes after ICH are understudied.
Mattias Tallroth, Ruzan Udumyan, András Büki, Mia von Euler   +3 more
doaj   +1 more source

Progress in the Application of Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation and Chronic Renal Insufficiency

Xiehe Yixue Zazhi, 2022
Oral anticoagulants can effectively reduce the risk of stroke in patients with atrial fibrillation. However, patients with atrial fibrillation and chronic renal insufficiency have an increased risk in both stroke and bleeding, making anticoagulant ...
LI Xin, LIU Lu, LIU Zhihong, ZHAO Zhihui, LUO Qin, ZHAO Qing   +5 more
doaj   +1 more source